ERBB2 and cancer: In HER-2 positive cancer (n = 41, table 5), however, DFS (Log-rank test: P = 0.408, Fig. 4C) and OS (Log-rank test: P = 0.155, Fig. 4D) had no significant associations with CD8+ CTLs infiltrate status.